OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 14 results

Filters: CB:18521990

Health Care of Elderly: A Viewpoint in Terms of Economic Evaluation.
Suguna Anbazhagan, A Surekha
Int J Prev Med. 2018.9:16 Electronic-eCollection
Source:PubMed
PMID: 29541431 doi:10.4103/ijpvm.IJPVM_357_16
Should all pharmacists in direct patient care settings be authorized to inject medications?
No authors listed
Can J Hosp Pharm. Jan, 2013.66(1):35-8 Print
Source:PubMed
PMID: 23463818 doi:10.4212/cjhp.v66i1.1210
Cost-effectiveness of a program to eliminate disparities in pneumococcal vaccination rates in elderly minority populations: an exploratory analysis.
Constantinos I Michaelidis, Richard K Zimmerman, Mary Patricia Nowalk, Kenneth J Smith
Value Health. 2013 Mar-Apr.16(2):311-7 Print
Source:PubMed
PMID: 23538183 doi:10.1016/j.jval.2012.11.009
Standing orders for influenza and pneumococcal polysaccharide vaccination: correlates identified in a national survey of U.S. Primary care physicians.
Steven M Albert, Mary Patricia Nowalk, Michael A Yonas, Richard K Zimmerman, Faruque Ahmed
BMC Fam Pract. Mar 20, 2012.13:22 Electronic
Source:PubMed
PMID: 22433118 doi:10.1186/1471-2296-13-22
Cost-effectiveness of pneumococcal and influenza vaccination standing order programs.
Chyongchiou Jeng Lin, Richard K Zimmerman, Kenneth J Smith
Am J Manag Care. 01 01, 2013.19(1):e30-7 Electronic
Source:PubMed
PMID: 23379777 doi:
A comparative public health and budget impact analysis of pneumococcal vaccines: The French case.
Yiling Jiang, Frédéric Gervais, Aline Gauthier, Charles Baptiste, Prescilla Martinon, Xavier Bresse
Hum Vaccin Immunother. 2015.11(9):2188-97 Print-Electronic
Source:PubMed
PMID: 26267239 doi:10.1080/21645515.2015.1011957
Cost of pneumococcal infections and cost-effectiveness analysis of pneumococcal vaccination at risk adults and elderly in Turkey.
Levent Akin, Mehmet Kaya, Serdar Altinel, Laure Durand
Hum Vaccin. Apr, 2011.7(4):441-50 Print-Electronic
Source:PubMed
PMID: 21441776 doi:10.4161/hv.7.4.14188
Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States.
Constantinos I Michaelidis, Richard K Zimmerman, Mary Patricia Nowalk, Kenneth J Smith
BMC Public Health. Jul 15, 2014.14:718 Electronic
Source:PubMed
PMID: 25023889 doi:10.1186/1471-2458-14-718
Incidence and economical effects of pneumonia in the older population living in French nursing homes: design and methods of the INCUR study.
Laurent Demougeot, Yves Rolland, Stéphane Gérard, Delphine Pennetier, Marilyne Duboué, Bruno Vellas, Matteo Cesari
BMC Public Health. Sep 17, 2013.13:861 Electronic
Source:PubMed
PMID: 24044421 doi:10.1186/1471-2458-13-861
Cost-effectiveness analysis of pneumococcal polysaccharide vaccination from age 60 in São Paulo State, Brazil.
Joao Tonolio Neto, Gabriela Tannus Branco de Araujo, Anna Gagliardi, Amanda Pinho, Laure Durand, Marcelo Fonseca
Hum Vaccin. Oct, 2011.7(10):1037-47 Print-Electronic
Source:PubMed
PMID: 21941088 doi:10.4161/hv.7.10.15987
0